文献速递头颈部肿瘤放疗

MDASI头颈吞咽与呛咳条目对影像分级吞咽困难的判别能力

Individual patient-reported symptom items discriminate imaging-graded dysphagia in head and neck cancer patients treated with radiotherapy: secondary analysis of pooled prospective studies.
PubMed 文献 · Radiother Oncol · 2026-01-06

该研究基于264例接受放疗的头颈癌患者的前瞻性注册数据,比较MDASI-HN吞咽与呛咳条目阈值与DIGEST影像分级吞咽困难的判别能力。预设阈值≥6特异度高但敏感度低,数据驱动阈值≥1-2敏感度更优,支持早期筛查。

要点

  • MDASI吞咽或呛咳≥6对中重度吞咽困难特异度高但敏感度低。
  • 较低阈值(≥1-2)可提高敏感度,利于早期发现吞咽障碍。
  • 呛咳≥1对误吸风险敏感度高,呛咳≥2可提高特异度。

核心结论

  • MDASI吞咽与呛咳条目与影像分级吞咽困难相关,≥6可标记中重度损害,但更低阈值(≥1-2)敏感度更优,支持早期检测。

研究设计与样本

  • 单中心前瞻性注册数据的回顾性二次分析,纳入264例接受放疗且完成MDASI-HN与改良钡吞咽检查的头颈癌患者。

主要发现

  • 吞咽≥6与DIGEST总体D≥1和D≥2相关(RR=1.8-2.6,p<0.05),特异度92-95%,敏感度23-30%。
  • 呛咳≥6与D≥2关联更强(RR=3.5,p<0.05),敏感度与特异度呈现类似权衡。
  • 数据驱动阈值提高准确性:D≥1时吞咽或呛咳≥2敏感度77%、特异度64%;D≥2时呛咳≥1敏感度85%、特异度69%,呛咳≥2特异度升至84%。
  • 误吸风险S≥2时,呛咳≥1敏感度88%、特异度66%;呛咳≥2特异度升至83%。

关键数值与推荐

  • 预设阈值MDASI吞咽或呛咳≥6。
  • 数据驱动阈值:吞咽或呛咳≥2用于D≥1;呛咳≥1或≥2用于D≥2;呛咳≥1或≥2用于S≥2。
  • 参考标准为DIGEST总体D、效率E、安全S≥1(任何损害)和≥2(中重度)。

临床怎么用

  • 临床筛查可考虑采用较低阈值(≥1-2)以提高对吞咽困难和误吸风险的敏感度,结合影像分级进行早期干预。

局限性

  • 回顾性二次分析、单中心数据,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To determine clinically actionable thresholds for the MD Anderson Symptom Inventory-Head and Neck (MDASI-HN) -Swallow and -Choke items by comparing discriminant capacity against imaging-based markers of dysphagia in head and neck cancer (HNC) patients undergoing (chemo)radiotherapy (RT). MATERIALS AND METHODS: A retrospective secondary analysis used single-institution prospective registries of HNC patients treated with RT who completed the MDASI-HN and a modified barium swallow (MBS) before, during, or after RT. The DynamicImaging Grade ofSwallowing Toxicity(DIGEST) overall (D), efficiency (E), and safety (S) scores were compared to a priori-defined (≥6) and data-driven thresholds using binomial regression. Diagnostic accuracy was evaluated using sensitivity (SN), specificity (SP), PPV and NPV, using DIGEST D, E, S ≥ 1 (any impairment) and ≥ 2 (moderate-severe) as reference standards. RESULTS: Among 264 patients (mean age 62; 87 % male; 47 % nasopharyngeal cancer; 55 % post-RT), -Swallow ≥ 6 was associated with D ≥ 1 and D ≥ 2 (RRs = 1.8-2.6, p < 0.05), showing high SP (92-95 %) but low SN (23-30 %). -Choke ≥ 6 demonstrated stronger associations for D ≥ 2 (RR = 3.5, p < 0.05), and similar SN/SP tradeoffs. Data-driven thresholds improved accuracy: for D ≥ 1, a combined threshold (-Swallow or -Choke) ≥ 2 yielded SN 77 %, SP 64 %; for D ≥ 2, -Choke ≥ 1 showed SN 85 %, SP 69 %, while -Choke ≥ 2 increased SP to 84 %. For aspiration risk (S ≥ 2), -Choke ≥ 1 had SN 88 %, SP 66 %; -Choke ≥ 2 improved SP to 83 %. CONCLUSION: MDASI-Swallow and -Choke correlate with imaging-based dysphagia. While ≥ 6 may flag moderate-severe impairment, lower thresholds (≥1-2) offer better sensitivity, supporting early detection. Combined thresholds may enhance screening and guide survivorship care.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Manduchi B, Jefferson TC, Moreno AC, et al. Individual patient-reported symptom items discriminate imaging-graded dysphagia in head and neck cancer patients treated with radiotherapy: secondary analysis of pooled prospective studies. Radiother Oncol. 2026. PMID: 41506576. doi:10.1016/j.radonc.2026.111365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。